Although the physiology of normal sexual intercourse is not yet suf®ciently elucidated, the studies referring to the cause of premature ejaculation (PE) seem to be fairly advanced. Thus, attempts are made to explain the etiology of PE by factors generating and maintaining this dysfunction, in close relationship with`the importance of physiological spinal ejaculatory mechanism to the understanding of PE'. 1 ± 3 By changing the order of approaching this subject (at ®rst the physiology and then a possible pathophysiology), conclusions may be drawn which require a revision of the current trends.
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The psychosensory sexual excitation is sympathoparasympathetically (Sp ± Pp) mediated. 2, 4, 5 The Sp sexual excitation assures the emission re¯ex, while the expulsion re¯ex is a somatic effector answer, 2 probably with a Pp origin.
Classically, the physiological sexual excitation is induced in men by testosterone (Tt) and in women by estrogens (Es). The Tt ± Es antagonism is often invoked, as multiple situations suggest it. (Tt antagonizes the maternal estrogens, inducing a male foetus, Es have favourable effects in androgendependent cancer of the prostate, Es mediate the Sp activity of the smooth musculature, while Tt is involved in its Pp activity, etc. 6 The Tt ± Es antagonism probably also manifests itself at the level of the antagonistic sexual excitation centres Pp ± Sp. Thus, the ®rst response of a man (with a normal, ie dominant level of Tt) to an ef®cient sexual stimulation is the erection of the penis. Before ejaculation, lubricating¯uid is eliminated from the seminal vesicles. In the female (with a dominant level of Es), the ®rst response to an ef®cient sexual stimulation consists in the lubrication of the vagina, while the intumescence of the erectile genital organs occurs afterwards. In a succession of orgasms, the ®rst is the most intensely perceived by the male, while in the female it is the last which attains the highest intensity. 7 In women, the Sp sexual excitation could be controlled by Es and the Pp sexual excitation by progesterone, a weak androgenic hormone. The libido is at its maximum in women during ovulation, when a concomitent secretion of the two hormones takes place. 6 The Pp sexual excitation in the male could be controlled by Tt, whereas the Sp sexual excitation could be controlled by a weak estrogenic stimulation. The administration of clomiphene (a weak estrogenic agonist) is useful as a sexual dynamic stimulation test in the male. Small amounts of Es are produced in the male through intervention of aromatasis, present in the brain, the testis and the skin (especially in the skin of the genital area), organs directly involved in the sexual excitation process. The administration of antiandrogens frequently induces gynecomastia by inversion of the activity ratio between Tt and Es. 6 Probably, the mixed Pp ± Sp sexual excitation process is possible by a positive feedback mechanism. Thus, this mechanism presumes the involvement of some protection system when the Pp ± Sp level of sexual excitation attains a certain degree. Serotonin intervenes in aggression (affect, anxiety, etc), so it is possibly involved in the central Sp(emission) ± Pp(expulsion) tension release mechanism. Hence, the orgasm may be the clinical (serotonin-mediated) expression of this concomitant Pp ± Sp tension release, expressed differently (in dynamics) in women and men in dependence on the type of the dominant autonomic component.
Sexual dysfunction may occur at one or more of the phases in the physiological sexual response cycle: desire (libido), arousal (excitement), ejaculation and orgasm (`PE is a dysfunction of the orgasm phase'). 3 Among the sexual side effects (in patients without PE) most commonly associated with selective serotonin reuptake inhibitor drugs (SSRIs) are delayed ejaculation and absent or delayed orgasm. These effects are present also in subjects with PE, so that SSRIs seem to be a successful treatment of PE. However, an effective (curable) treatment with SSRIs of PE cases is rather dif®cult, so that the therapy has the signi®cance of a symptomatic treatment. 8 Some literature data suggest that the disturbances occurring in PE involve the processes preceding the ejaculation and the orgasm, namely desire and arousal. 2, 4 In the case of the process of sexual excitation, the impairments may develop either towards a Sp dominance (PE plus erectile dysfunction Ð ED) 4 or probably towards a Pp dominance (pure PE). The pure PE associates the same type of impairments as the pure ED (without PE association). Nevertheless, PE plus ED represents a distinct clinical entity, which manifests itself by disturbances opposite to those existent in the pure PE. 2 The multiple factors (hormonal, etc) which may be incriminated induce relative or absolute imbalances; thus, forms of PE were described in which only seminal emission occurs, without subsequent seminal expulsion. 2 Consequently, the physiological ejaculation re¯ex cannot be studied separately from the complex sexual excitation process and a possible role of Es in the male excitation process, not only the level of Tt, 9,10 should be taken into account, since the augmentation of the excitation concomitantly at the level of two antagonistic centres by a single mediator is not possible.
